Ionis Pharmaceuticals Inc (IONS)
36.55
+0.47
(+1.30%)
USD |
NASDAQ |
Dec 24, 13:00
36.55
0.00 (0.00%)
After-Hours: 13:59
Ionis Pharmaceuticals Cash from Investing (Quarterly): -340.80M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Biogen Inc | -1.181B |
| Biomarin Pharmaceutical Inc | -16.16M |
| Regeneron Pharmaceuticals Inc | -574.40M |
| Apellis Pharmaceuticals Inc | 0.00 |
| Moderna Inc | 721.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -114.99M |
| Cash from Financing (Quarterly) | 496.05M |
| Free Cash Flow | -374.21M |
| Free Cash Flow Per Share (Quarterly) | -0.749 |
| Free Cash Flow to Equity (Quarterly) | -112.78M |
| Free Cash Flow to Firm (Quarterly) | -89.13M |
| Free Cash Flow Yield | -7.02% |